By suppressing the mitogen-activated protein kinase (MAPK)-mediated inflammatory response, baicalin reduced the expression of pro-inflammatory factors such as IL-1β and IL-6 and alleviated inflammatory damage in DKD mice [62]. Here, IL6 is linked to diabetic kidney disease.